Literature DB >> 16378762

The expression patterns of deubiquitinating enzymes, USP22 and Usp22.

Hey-Jin Lee1, Myung-Sun Kim, Ju-Mi Shin, Tae-Jin Park, Hyung-Min Chung, Kwang-Hyun Baek.   

Abstract

Deubiquitinating enzymes regulate a number of cellular mechanisms including pre-implantation, growth and differentiation, oncogenesis, cell cycle progression, transcriptional activation, and signal transduction. In this study, we have identified a novel human deubiquitinating enzyme gene, USP22, and its mouse homologue, Usp22. They encode 525 amino acids (approximate MW: 60kDa) and contains Cys, Asp (I), His and Asp/Asn (II), the highly conserved domains of the UBP family of deubiquitinating enzymes. The biochemical assay revealed that they have deubiquitinating enzyme activity. Northern blot analysis for USP22 showed moderate expression in various organs including human heart and skeletal muscle, and weak expression in lung and liver. However, Usp22 is expressed strongly in brain and weakly in other organs. We investigated the expression level of Usp22 mRNA and the localization during implantation and early pregnancy by in situ hybridization. Interestingly, Northern blot analysis showed the strong expression of Usp22 between embryonic days E10.5 and E12.5. Whole mount in situ hybridization staining revealed that Usp22 was expressed in the midbrain, forebrain, hindbrain and dorsal root ganglia of embryos at E12.5. Embryos at E12.5 showed the pronounced expression of Usp22 during the early embryonic development, although its expression was not detectable in the gut, liver and heart.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378762     DOI: 10.1016/j.modgep.2005.07.007

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  42 in total

Review 1.  The role of deubiquitinating enzymes in chromatin regulation.

Authors:  Boyko S Atanassov; Evangelia Koutelou; Sharon Y Dent
Journal:  FEBS Lett       Date:  2010-10-26       Impact factor: 4.124

2.  p38 mitogen-activated protein kinase inhibits USP22 transcription in HeLa cells.

Authors:  Jianjun Xiong; Zhen Gong; Xiaou Zhou; Jianyun Liu; H E Jiang; Ping Wu; Weidong Li
Journal:  Biomed Rep       Date:  2015-04-16

3.  USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma.

Authors:  Jun Li; Zhou Wang; Yu Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-25       Impact factor: 4.553

Review 4.  Regulation of pluripotency and differentiation by deubiquitinating enzymes.

Authors:  B Suresh; J Lee; H Kim; S Ramakrishna
Journal:  Cell Death Differ       Date:  2016-06-10       Impact factor: 15.828

5.  Dissenting degradation: Deubiquitinases in cell cycle and cancer.

Authors:  Thomas Bonacci; Michael J Emanuele
Journal:  Semin Cancer Biol       Date:  2020-03-20       Impact factor: 15.707

6.  High expression of ubiquitin carboxyl-terminal hydrolase 22 is associated with poor prognosis in hepatitis B virus-associated liver cancer.

Authors:  Yong Liao; Xingsi Liang; Wenjin Liang; Zeming Li; Yan Wang; Lin Wang; Siqi Zhen; Bo Tang; Zhenran Wang
Journal:  Oncol Lett       Date:  2019-03-15       Impact factor: 2.967

7.  ShRNA-mediated silencing of the ubiquitin-specific protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyngeal carcinoma.

Authors:  Ya-Jing Zhuang; Zhi-Wei Liao; Hong-Wei Yu; Xian-Lu Song; Yuan Liu; Xing-Yuan Shi; Xiao-Dan Lin; Tong-Chong Zhou
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

8.  The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.

Authors:  Xiao-Yong Zhang; Maya Varthi; Stephen M Sykes; Charles Phillips; Claude Warzecha; Wenting Zhu; Anastasia Wyce; Alan W Thorne; Shelley L Berger; Steven B McMahon
Journal:  Mol Cell       Date:  2008-01-18       Impact factor: 17.970

9.  Host factors required for modulation of phagosome biogenesis and proliferation of Francisella tularensis within the cytosol.

Authors:  Christine Akimana; Souhaila Al-Khodor; Yousef Abu Kwaik
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

10.  Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics.

Authors:  Jun Liang; Xianli Zhang; Shao Xie; Xiuping Zhou; Qiong Shi; Jinxia Hu; Weifeng Wang; Weifeng Qi; Rutong Yu
Journal:  Med Oncol       Date:  2014-02-27       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.